226 related articles for article (PubMed ID: 33322849)
1. Disposition of Cannabidiol Metabolites in Serum and Urine from Healthy Individuals Treated with Pharmaceutical Preparations of Medical Cannabis.
Pérez-Acevedo AP; Busardò FP; Pacifici R; Mannocchi G; Gottardi M; Poyatos L; Papaseit E; Pérez-Mañá C; Martin S; Di Trana A; Pichini S; Farré M
Pharmaceuticals (Basel); 2020 Dec; 13(12):. PubMed ID: 33322849
[TBL] [Abstract][Full Text] [Related]
2. Disposition of cannabinoids and their metabolites in serum, oral fluid, sweat patch and urine from healthy individuals treated with pharmaceutical preparations of medical cannabis.
Pérez-Acevedo AP; Pacifici R; Mannocchi G; Gottardi M; Poyatos L; Papaseit E; Pérez-Mañá C; Martin S; Busardò FP; Pichini S; Farré M
Phytother Res; 2021 Mar; 35(3):1646-1657. PubMed ID: 33155722
[TBL] [Abstract][Full Text] [Related]
3. Ultra-high-performance liquid chromatography-tandem mass spectrometry assay for quantifying THC, CBD and their metabolites in hair. Application to patients treated with medical cannabis.
Lo Faro AF; Venanzi B; Pilli G; Ripani U; Basile G; Pichini S; Busardò FP
J Pharm Biomed Anal; 2022 Aug; 217():114841. PubMed ID: 35636009
[TBL] [Abstract][Full Text] [Related]
4. Cannabidiol, ∆
Pigliasco F; Malaca S; Lo Faro AF; Tini A; Cangemi G; Cafaro A; Barco S; Riva A; Pisati A; Amadori E; Striano P; Tagliabracci A; Huestis MA; Busardò FP
Front Pharmacol; 2022; 13():1038754. PubMed ID: 36353497
[TBL] [Abstract][Full Text] [Related]
5. UHPLC-MS/MS analysis of cannabidiol metabolites in serum and urine samples. Application to an individual treated with medical cannabis.
Pichini S; Malaca S; Gottardi M; Pérez-Acevedo AP; Papaseit E; Perez-Maña C; Farré M; Pacifici R; Tagliabracci A; Mannocchi G; Busardò FP
Talanta; 2021 Feb; 223(Pt 2):121772. PubMed ID: 33298281
[TBL] [Abstract][Full Text] [Related]
6. Disposition of Phytocannabinoids, Their Acidic Precursors and Their Metabolites in Biological Matrices of Healthy Individuals Treated with Vaporized Medical Cannabis.
Busardò FP; Pérez-Acevedo AP; Pacifici R; Mannocchi G; Gottardi M; Papaseit E; Pérez-Mañá C; Martin S; Poyatos L; Pichini S; Farré M
Pharmaceuticals (Basel); 2021 Jan; 14(1):. PubMed ID: 33451073
[TBL] [Abstract][Full Text] [Related]
7. UHPLC-MS/MS Analysis of Cannabidiol and Its Metabolites in Serum of Patients with Resistant Epilepsy Treated with CBD Formulations.
Malaca S; Gottardi M; Pigliasco F; Barco S; Cafaro A; Amadori E; Riva A; Marcenaro M; Striano P; Cangemi G; Pacifici R; Pichini S; Busardò FP
Pharmaceuticals (Basel); 2021 Jun; 14(7):. PubMed ID: 34209666
[TBL] [Abstract][Full Text] [Related]
8. A Randomized, Triple-Blind, Comparator-Controlled Parallel Study Investigating the Pharmacokinetics of Cannabidiol and Tetrahydrocannabinol in a Novel Delivery System, Solutech, in Association with Cannabis Use History.
Berl V; Hurd YL; Lipshutz BH; Roggen M; Mathur EJ; Evans M
Cannabis Cannabinoid Res; 2022 Dec; 7(6):777-789. PubMed ID: 35787693
[No Abstract] [Full Text] [Related]
9. Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extract.
Nadulski T; Sporkert F; Schnelle M; Stadelmann AM; Roser P; Schefter T; Pragst F
J Anal Toxicol; 2005; 29(8):782-9. PubMed ID: 16356335
[TBL] [Abstract][Full Text] [Related]
10. Fast and sensitive UHPLC-MS/MS analysis of cannabinoids and their acid precursors in pharmaceutical preparations of medical cannabis and their metabolites in conventional and non-conventional biological matrices of treated individual.
Pichini S; Mannocchi G; Gottardi M; Pérez-Acevedo AP; Poyatos L; Papaseit E; Pérez-Mañá C; Farré M; Pacifici R; Busardò FP
Talanta; 2020 Mar; 209():120537. PubMed ID: 31892011
[TBL] [Abstract][Full Text] [Related]
11. UHPLC-MS-MS Determination of THC, CBD and Their Metabolites in Whole Blood of Light Cannabis Smokers.
Lo Faro AF; Tini A; Gottardi J; Pichini S; Carlier J; Giorgetti R; Busardò FP
J Anal Toxicol; 2023 Jan; 46(9):e256-e261. PubMed ID: 36214389
[TBL] [Abstract][Full Text] [Related]
12. Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract.
Nadulski T; Pragst F; Weinberg G; Roser P; Schnelle M; Fronk EM; Stadelmann AM
Ther Drug Monit; 2005 Dec; 27(6):799-810. PubMed ID: 16306858
[TBL] [Abstract][Full Text] [Related]
13. A validated method for the simultaneous quantification of cannabidiol, Δ
Kevin RC; Vogel R; Doohan P; Berger M; Amminger GP; McGregor IS
Drug Test Anal; 2021 Mar; 13(3):614-627. PubMed ID: 33095968
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of Action and Pharmacokinetics of Cannabis.
Chayasirisobhon S
Perm J; 2020 Dec; 25():1-3. PubMed ID: 33635755
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of cannabinoids concentration and stability in standardized preparations of cannabis tea and cannabis oil by ultra-high performance liquid chromatography tandem mass spectrometry.
Pacifici R; Marchei E; Salvatore F; Guandalini L; Busardò FP; Pichini S
Clin Chem Lab Med; 2017 Aug; 55(10):1555-1563. PubMed ID: 28207408
[TBL] [Abstract][Full Text] [Related]
16. Will tetrahydrocannabinol be formed from cannabidiol in gastric fluid? An in vivo experiment.
Franz S; Herzog J; Skopp G; Musshoff F
Int J Legal Med; 2023 Jan; 137(1):79-87. PubMed ID: 36190564
[TBL] [Abstract][Full Text] [Related]
17. The cross-reactivity of cannabinoid analogs (delta-8-THC, delta-10-THC and CBD), their metabolites and chiral carboxy HHC metabolites in urine of six commercially available homogeneous immunoassays.
Wolf CE; Pokhai AA; Poklis JL; Williams GR
J Anal Toxicol; 2023 Nov; 47(8):732-736. PubMed ID: 37602947
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of Cannabidiol, Cannabidiolic Acid, Δ9-Tetrahydrocannabinol, Tetrahydrocannabinolic Acid and Related Metabolites in Canine Serum After Dosing With Three Oral Forms of Hemp Extract.
Wakshlag JJ; Schwark WS; Deabold KA; Talsma BN; Cital S; Lyubimov A; Iqbal A; Zakharov A
Front Vet Sci; 2020; 7():505. PubMed ID: 33102539
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of Cannabidiol in Sprague-Dawley Rats After Oral and Pulmonary Administration.
Schwotzer D; Kulpa J; Trexler K; Dye W; Jantzi J; Irshad H; Ware MA; Bonn-Miller M; McDonald J; Lefever T
Cannabis Cannabinoid Res; 2023 Apr; 8(2):360-373. PubMed ID: 36301522
[No Abstract] [Full Text] [Related]
20. Heat exposure of Cannabis sativa extracts affects the pharmacokinetic and metabolic profile in healthy male subjects.
Eichler M; Spinedi L; Unfer-Grauwiler S; Bodmer M; Surber C; Luedi M; Drewe J
Planta Med; 2012 May; 78(7):686-91. PubMed ID: 22411724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
